GuidelineReproductive sciences (Thousand Oaks, Calif.)2025
Strategic Guidelines to Integrate Artificial Intelligence in Obstetrics and Gynecology: Best Practices and Ethical Considerations.
Guideline in Reproductive sciences (Thousand Oaks, Calif.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The transformative advancements in artificial intelligence (AI) have significantly impacted medical fields, particularly obstetrics and gynecology (OBGYN). This manuscript presents a comprehensive set of twelve strategic guidelines for the effective integration of AI into OBGYN, emphasizing both best practices and ethical considerations. These guidelines cover essential domains including multidisciplinary collaboration, safeguarding patient safety and privacy, continuous staff training, mitigating algorithmic bias, promoting transparent communication with patients, and fostering a continuous feedback loop between clinicians and AI developers. Additional recommendations highlight the importance of staying updated on AI advancements, defining the role of AI within clinical governance frameworks, ensuring long-term sustainability, collaborating with AI vendors for customized solutions, and evaluating outcomes to inform future practice. These strategies are designed to position AI as an augmentative tool in clinical decision-making, ensuring it enhances rather than replaces human expertise. By upholding collaborative efforts and ethical standards, AI can profoundly improve care quality in OBGYN, fostering safer and more effective healthcare delivery.
Indexed as
Identifiers
40524101What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.